Vol 15, No 5 (October 30, 2026): Chinese Clinical Oncology

Original Article

Association between preoperative multidisciplinary team discussion and survival outcomes in patients with colorectal cancer liver metastases undergoing initial hepatic resection: a single-center retrospective cohort study
Yan Liu, Long Chen, Huachuan Song, Wei Cai, Ruipeng Song, Yongliang Zhang, Jizhou Wang
Chinese Clinical Oncology  
2026;
15
(5)
:65
.
Burden of sarcopenia and impact of structured physical programme in children with acute lymphoblastic leukaemia
Iris Y. M. Lim, Joanna Y. L. Tung, Anthony P. Y. Liu, Becky P. K. Tsang, Sarah W. Y. Poon, K. S. Ng, Stephen W. W. Chan, Frankie W. T. Cheng
Chinese Clinical Oncology  
2026;
15
(5)
:66
.
Prognostic comparison between male and female breast cancer: a population-based SEER database study
Yong Chen, Hui Wang
Chinese Clinical Oncology  
2026;
15
(5)
:67
.
A real-world observation on treatment patterns among Chinese patients with advanced esophageal cancer: a multicenter cross-sectional analysis
Xianjun Zhao, Leilin Zhu, Jianzhuang Guo, Xianru Zhang, Hongwei Cai, Yong Wang, Ye Qian, Aiting Yan, Dongmei Ai, Jian Zhang, Zongtai Li, Zunbei Wen
Chinese Clinical Oncology  
2026;
15
(5)
:68
.

Review Article

Hepatic surgery for breast cancer liver metastases in the modern systemic therapy era: narrative review of evidence, patient selection, and a multidisciplinary decision framework
José Ramón Oliver-Guillén, José Manuel Ramia, Mario Serradilla-Martín
Chinese Clinical Oncology  
2026;
15
(5)
:69
.
Phosphaturic mesenchymal tumor—narrative review of the diagnostic challenges and modern treatment
Paulina Chmiel, Aneta Borkowska, Michał Wągrodzki, Irmina Michałek, Piotr Rutkowski, Mateusz Spałek
Chinese Clinical Oncology  
2026;
15
(5)
:70
.

Commentary

One size does not fit all: the inclusion of carboplatin in neoadjuvant treatment of triple-negative breast cancer
Vishnu Prasath, Emily Cybulla, Aminatta Mitchell, Dionisia Quiroga
Chinese Clinical Oncology  
2026;
15
(5)
:71
.